RICHMOND, Calif., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company,
today announced that it will release financial and business results for the third quarter 2016 after the close of trading on
Wednesday, November 9, 2016. The Company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT /
4:30 p.m. ET to discuss the financial results and recent business developments.
Investors interested in listening to the conference call may do so by dialing (877) 407-3036 for domestic callers or (201)
378-4919 for international callers, or from the webcast on the “Investor Relations” section of the Company’s website at: www.eksobionics.com.
A replay of the call will be available beginning November 9, 2016 at 4:30 p.m. PT / 7:30 p.m. ET through midnight ET on November
23, 2016. To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Conference ID: 13581989. The webcast will also
be available on the Company’s website for one month following the completion of the call.
About Ekso Bionics®
Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength,
endurance and mobility across medical, industrial and defense applications. Founded in 2005, the Company continues to build upon
its unparalleled expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso
Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to
enhancing human capabilities on job sites across the globe, to providing research for the advancement of R&D projects intended
to benefit U.S. defense capabilities. The Company is headquartered in the Bay Area and is listed on the Nasdaq Capital Market under
the symbol EKSO. For more information, visit: www.eksobionics.com.
Media Contact: Carrie Yamond / Rajni Dhanjani 212-867-1788 cyamond@lazarpartners.com Investor Contact: Debbie Kaster 415-937-5403 investors@eksobionics.com
